-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Aurinia Pharmaceuticals Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q2 2024.
- Aurinia Pharmaceuticals Inc. Costs and Expenses for the quarter ending June 30, 2024 was $58.7M, a 1.81% increase year-over-year.
- Aurinia Pharmaceuticals Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $268M, a 10% increase year-over-year.
- Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2023 was $267M, a 8.84% increase from 2022.
- Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2022 was $246M, a 8.47% increase from 2021.
- Aurinia Pharmaceuticals Inc. annual Costs and Expenses for 2021 was $226M, a 46.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)